Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results

Go back to Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
(NASDAQ: LRMR) Delayed: 3.25 +0.05 (1.56%)
Previous Close $3.20    52 Week High
Open $3.23    52 Week Low
Day High $3.35    P/E N/A 
Day Low $3.15    EPS
Volume 1,278,874